US2011165668A1PendingUtilityA1

MHC Class I Peptide Epitopes from the Human 5T4 Tumor-Associated Antigen

Assignee: OXFORD BIOMEDICA LTDPriority: Feb 13, 2002Filed: Jan 3, 2011Published: Jul 7, 2011
Est. expiryFeb 13, 2022(expired)· nominal 20-yr term from priority
C07K 1/061A61P 37/04C07K 14/4748A61P 35/00A61K 39/00A61K 2039/5154A61K 2039/5158
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

There is provided an MHC class I peptide epitope from 5T4 antigen. In particular, there is provided a peptide epitope of 5T4 which comprises one of the following: (i) the amino acid sequence shown as SEQ ID NO: 2; (ii) the minimal epitope from the amino acid sequence shown as SEQ ID NO: 3; (iii) the minimal epitope from the amino acid sequence shown as SEQ ID NO: 4; (iv) the minimal epitope from the amino acid sequence shown as SEQ ID NO: 5; (v) the minimal epitope from the amino acid sequence shown as SEQ ID NO: 6; (vi) the minimal epitope from the amino acid sequence shown as SEQ ID NO: 7. There is also provided a vaccine comprising such a peptide (or precursor thereof) and its use to treat and/or prevent a disease, in particular a cancerous disease.

Claims

exact text as granted — not AI-modified
1 - 21 . (canceled) 
     
     
         22 . A nucleic acid molecule capable of encoding an MHC class I peptide epitope of 5T4 comprising the amino acid sequence set forth in SEQ ID NO: 8. 
     
     
         23 . A vector comprising the nucleic acid molecule of  claim 22 .

Join the waitlist — get patent alerts

Track US2011165668A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.